(410 ILCS 416/20)
    Sec. 20. Requirements; notice.
    (a) The program:
        (1) must collaborate with physicians, health care
    
providers, and clinical trial sponsors to notify a prospective subject about the program when:
            (A) the prospective subject consents to a
        
clinical trial; or
            (B) funding is available to provide the program
        
for the clinical trial in which the prospective subject participates;
        (2) must reimburse subjects based on financial need,
    
which may include reimbursement to subjects whose income is at or below 700% of the federal poverty level;
        (3) must provide reimbursement for ancillary costs,
    
including costs described under Section 15, to eliminate the financial barriers to enrollment in a clinical trial;
        (4) may provide reimbursement for reasonable
    
ancillary costs, including costs described under Section 15, to one family member, friend, or other person who attends a clinical trial to support a subject; and
        (5) must comply with applicable federal and State
    
laws.
    (b) The independent third-party organization administering the program shall provide written notice to prospective subjects of the requirements described under subsection (a).
(Source: P.A. 103-227, eff. 6-30-23.)